Adamis Pharmaceuticals share#snapshot#suffix 127206734 / US00547W3079
0.00
EUR
0.00
EUR
0.00
%
11:55:16
XQTX
| prices + charts + realtime | news + analysis | fundamental | company | corresponding shares | action | |
|---|---|---|---|---|---|---|
| price + Chart | chart (large) | news + ad-hoc | balance sheet/p&l | fixed dates | certificates | portfolio#add_instrument_to#depot |
| times + sale | chart comparison | analysis | detailnavigation#shares#estimates | profile | portfolio#add_instrument_to#watchlist | |
| stock exchange | realtime push | stock price appreciation potential | dividend/annual shareholders' meeting | |||
| historic | analysis | |||||
prices + charts + realtime
news + analysis
fundamental
company
corresponding shares
Adamis Pharmaceuticals Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2022 | Adamis Pharmaceuticals Corp Registered Shs | 0.00 | 0.00 | USD |
| 2021 | Adamis Pharmaceuticals Corp Registered Shs | 0.00 | 0.00 | USD |
| 2020 | Adamis Pharmaceuticals Corp Registered Shs | 0.00 | 0.00 | USD |
| 2019 | Adamis Pharmaceuticals Corp Registered Shs | 0.00 | 0.00 | USD |
| 2018 | Adamis Pharmaceuticals Corp Registered Shs | 0.00 | 0.00 | USD |
| 2017 | Adamis Pharmaceuticals Corp Registered Shs | 0.00 | 0.00 | USD |
| 2016 | Adamis Pharmaceuticals Corp Registered Shs | 0.00 | 0.00 | USD |
| 2015 | Adamis Pharmaceuticals Corp Registered Shs | 0.00 | 0.00 | USD |
| 2014 | Adamis Pharmaceuticals Corp Registered Shs | 0.00 | 0.00 | USD |
| 2013 | Adamis Pharmaceuticals Corp Registered Shs | 0.00 | 0.00 | USD |
share#balance#profitpershare- Adamis Pharmaceuticals
| -12.6 22 | -22.4 21 | -44.8 20 | -38.5 19 | -70 18 | -63 17 | -83.3 16 |
share#balance#salespershare- Adamis Pharmaceuticals
| 2.2 22 | 1.1 21 | 14.9 20 | 29.1 19 | 27.0 18 | 32.3 17 | 25.9 16 |
share#balance#p_e_ratio- Adamis Pharmaceuticals
Adamis Pharmaceuticals Corp Registered Shs: share#balance#headline#theshare (in USD)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (berichtet) | -12.60 | -22.40 | -44.80 | -38.50 | -70.00 | -63.00 | -83.30 |
| Gewinn je Aktie (unverwässert) | -12.37 | -22.25 | -44.57 | -38.52 | -69.86 | -63.00 | -83.30 |
| Gewinn je Aktie (verwässert) | -12.37 | -22.25 | -44.57 | -38.52 | -69.86 | -63.00 | -83.30 |
| Dividende je Aktie | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Veränderung Dividende je Aktie in % | - | - | - | - | - | - | - |
| share#balance#cell#dividend_payment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adamis Pharmaceuticals Corp Registered Shs: share#balance#business_ratio (in USD)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales_share | 2.22 | 1.07 | 14.91 | 29.06 | 27.02 | 32.28 | 25.89 |
| KGV (Jahresendkurs, Gewinn unverwässert) | - | - | - | - | - | - | - |
| KGV (Jahresendkurs, Gewinn verwässert) | - | - | - | - | - | - | - |
| share#balance#cell#dividend_ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| share#balance#cell#equity_ratio | -5.95 | 67.58 | 11.18 | 73.14 | 80.01 | 76.94 | 66.90 |
| share#balance#cell#debt_ratio | 105.95 | 32.42 | 88.82 | 26.86 | 19.99 | 23.06 | 33.10 |
Adamis Pharmaceuticals Corp Registered Shs: share#balance#headline#income_statement (in Mio. USD)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales | 4.76 | 2.21 | 16.53 | 22.11 | 15.09 | 13.07 | 6.47 |
| share#balance#cell#sales_change | 115.34 | -86.64 | -25.26 | 46.58 | 15.40 | 101.94 | - |
| share#balance#cell#sales_gross_profit | -2.90 | -4.66 | 1.58 | 3.94 | 2.19 | 2.59 | -0.91 |
| share#balance#cell#sales_gross_profit_change | 37.86 | - | -59.76 | 79.73 | -15.44 | - | 7.67 |
| share#balance#cell#operating_income | -25.06 | -32.07 | -29.16 | -30.00 | -40.35 | -24.69 | -25.20 |
| share#balance#cell#operating_income_change | 21.86 | -9.98 | 2.81 | 25.65 | -63.42 | 2.03 | -81.98 |
| share#balance#cell#income_before_tax | -26.20 | -34.60 | -49.81 | -29.95 | -40.28 | -25.88 | -24.01 |
| share#balance#cell#income_before_tax_change | 24.28 | 30.54 | -66.31 | 25.64 | -55.63 | -7.77 | -76.92 |
| share#balance#cell#income_after_tax | -26.20 | -34.60 | -49.39 | -29.31 | -39.01 | -25.54 | -19.44 |
| share#balance#cell#income_after_tax_change | 24.28 | 29.95 | -68.53 | 24.87 | -52.73 | -31.39 | -43.22 |
Adamis Pharmaceuticals Corp Registered Shs: share#balance#headline#balance (in Mio. USD)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
| Fremdkapital | 12 | 12 | 28 | 13 | 12 | 12 | 13 |
| Langzeit Gesamtverbindlichk. je Aktie | 0.09 | 0.56 | 5.86 | 3.43 | 0.17 | 6.43 | 12.40 |
| share#balance#cell#total_equity | -1 | 26 | 3 | 36 | 47 | 40 | 25 |
| share#balance#cell#total_equity_change | -103.12 | 640.03 | -90.29 | -22.82 | 18.07 | 56.44 | 171.42 |
| share#balance#cell#total_liabilities_and_equity | 11 | 38 | 31 | 49 | 58 | 51 | 38 |
| share#balance#cell#total_liabilities_and_equity_change | -71.46 | 22.43 | -36.51 | -15.57 | 13.53 | 36.04 | 213.27 |
Adamis Pharmaceuticals Corp Registered Shs: share#balance#headline#other_data (in USD)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | -12.37 | -22.25 | -44.57 | -38.52 | -69.86 | -63.00 | -83.30 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 44.42 | 50.07 | -15.72 | 44.87 | -10.89 | 24.37 | -16.67 |
| Gewinn je Aktie (verwässert) | -12.37 | -22.25 | -44.57 | -38.52 | -69.86 | -63.00 | -83.30 |
| Veränderung Gewinn je Aktie (verwässert) in % | 44.42 | 50.07 | -15.72 | 44.87 | -10.89 | 24.37 | -15.53 |
| share#balance#cell#employees | 12 | 15 | 143 | 171 | 231 | 126 | 14 |
| share#balance#cell#employees_change | -20.00 | -89.51 | -16.37 | -25.97 | 83.33 | 800.00 | -12.50 |
Adamis Pharmaceuticals Corp Registered Shs Termine
| Unternehmen | Event | Datum |
|---|
Adamis Pharmaceuticals Corp Registered Shs vergangene Termine
| Terminart | Info | Datum |
|---|
share#companyprofile#balance#staff#headline
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#employees | 14 | 126 | 231 | 171 | 143 |
| share#companyprofile#balance#staff#salesperemployee | 0.46 | 0.10 | 0.07 | 0.13 | 0.12 |
Bilanz (in Mio. USD) - Aktiva
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#currentassets | 7 | 21 | 26 | 14 | 13 |
| share#companyprofile#balance#staff#fixedassets | 31 | 30 | 33 | 36 | 19 |
| share#companyprofile#balance#staff#totalassets | 38 | 51 | 58 | 49 | 31 |
Bilanz (in Mio. USD) - Passiva
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#totalborrowing | 13 | 12 | 12 | 13 | 28 |
| share#companyprofile#balance#staff#totalequity | 25 | 40 | 47 | 36 | 3 |
| share#companyprofile#balance#staff#totalliabilities | 38 | 51 | 58 | 49 | 31 |